Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Oncogene

Retrieve available abstracts of 77 articles:
HTML format

Single Articles

    July 2021
  1. KARUNANITHI S, Liu R, Hou Y, Gonzalez G, et al
    Thioredoxin reductase is a major regulator of metabolism in leukemia cells.
    Oncogene. 2021 Jul 8. pii: 10.1038/s41388-021-01924.
    PubMed     Abstract available

    May 2021
  2. YUSENKO MV, Trentmann A, Casolari DA, Abdel Ghani L, et al
    C/EBPbeta is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemia.
    Oncogene. 2021 May 6. pii: 10.1038/s41388-021-01800.
    PubMed     Abstract available

    April 2021
  3. ZHOU M, Zhang X, Liu C, Nie D, et al
    Targeting protein lysine methyltransferase G9A impairs self-renewal of chronic myelogenous leukemia stem cells via upregulation of SOX6.
    Oncogene. 2021 Apr 30. pii: 10.1038/s41388-021-01799.
    PubMed     Abstract available

  4. WEI Y, Lu W, Yu Y, Zhai Y, et al
    miR-29c&b2 encourage extramedullary infiltration resulting in the poor prognosis of acute myeloid leukemia.
    Oncogene. 2021 Apr 22. pii: 10.1038/s41388-021-01775.
    PubMed     Abstract available

  5. HAO T, Zhang C, Wang Z, Buck A, et al
    An aging mouse model of human chronic myeloid leukemia.
    Oncogene. 2021 Apr 6. pii: 10.1038/s41388-021-01770.
    PubMed     Abstract available

    March 2021
  6. BENCOMO-ALVAREZ AE, Rubio AJ, Olivas IM, Gonzalez MA, et al
    Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B.
    Oncogene. 2021 Mar 12. pii: 10.1038/s41388-021-01732.
    PubMed     Abstract available

    January 2021
  7. OCHIIWA H, Ailiken G, Yokoyama M, Yamagata K, et al
    TAS4464, a NEDD8-activating enzyme inhibitor, activates both intrinsic and extrinsic apoptotic pathways via c-Myc-mediated regulation in acute myeloid leukemia.
    Oncogene. 2021 Jan 8. pii: 10.1038/s41388-020-01586.
    PubMed     Abstract available

    November 2020
  8. KOSCHUT D, Ray D, Li Z, Giarin E, et al
    RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia.
    Oncogene. 2020 Nov 27. pii: 10.1038/s41388-020-01567.
    PubMed     Abstract available

    October 2020
  9. CHU Y, Chen Y, Guo H, Li M, et al
    SUV39H1 regulates the progression of MLL-AF9-induced acute myeloid leukemia.
    Oncogene. 2020 Oct 9. pii: 10.1038/s41388-020-01495.
    PubMed     Abstract available

    September 2020
  10. KARRA L, Romero-Moya D, Ksionda O, Krush M, et al
    Increased baseline RASGRP1 signals enhance stem cell fitness during native hematopoiesis.
    Oncogene. 2020 Sep 28. pii: 10.1038/s41388-020-01469.
    PubMed     Abstract available

  11. BONGIOVANNI D, Tosello V, Saccomani V, Dalla Santa S, et al
    Crosstalk between Hedgehog pathway and the glucocorticoid receptor pathway as a basis for combination therapy in T-cell acute lymphoblastic leukemia.
    Oncogene. 2020 Sep 11. pii: 10.1038/s41388-020-01453.
    PubMed     Abstract available

    August 2020
  12. TOTANI H, Shinjo K, Suzuki M, Katsushima K, et al
    Autocrine HGF/c-Met signaling pathway confers aggressiveness in lymph node adult T-cell leukemia/lymphoma.
    Oncogene. 2020 Aug 4. pii: 10.1038/s41388-020-01393.
    PubMed     Abstract available

  13. BURGESS M, Chen YCE, Mapp S, Blumenthal A, et al
    HDAC7 is an actionable driver of therapeutic antibody resistance by macrophages from CLL patients.
    Oncogene. 2020;39:5756-5767.
    PubMed     Abstract available

    July 2020
  14. TODA J, Ichii M, Oritani K, Shibayama H, et al
    Signal-transducing adapter protein-1 is required for maintenance of leukemic stem cells in CML.
    Oncogene. 2020 Jul 13. pii: 10.1038/s41388-020-01387.
    PubMed     Abstract available

    June 2020
  15. LIN CC, Yao CY, Hsu YC, Hou HA, et al
    Knock-out of Hopx disrupts stemness and quiescence of hematopoietic stem cells in mice.
    Oncogene. 2020 Jun 12. pii: 10.1038/s41388-020-1340.
    PubMed     Abstract available

    April 2020
  16. REDONDO MONTE E, Wilding A, Leubolt G, Kerbs P, et al
    ZBTB7A prevents RUNX1-RUNX1T1-dependent clonal expansion of human hematopoietic stem and progenitor cells.
    Oncogene. 2020;39:3195-3205.
    PubMed     Abstract available

    March 2020
  17. FLOREN M, Restrepo Cruz S, Termini CM, Marjon KD, et al
    Tetraspanin CD82 drives acute myeloid leukemia chemoresistance by modulating protein kinase C alpha and beta1 integrin activation.
    Oncogene. 2020 Mar 19. pii: 10.1038/s41388-020-1261.
    PubMed     Abstract available

  18. SHIBATA N, Ohoka N, Tsuji G, Demizu Y, et al
    Deubiquitylase USP25 prevents degradation of BCR-ABL protein and ensures proliferation of Ph-positive leukemia cells.
    Oncogene. 2020 Mar 12. pii: 10.1038/s41388-020-1253.
    PubMed     Abstract available

  19. LI Z, Philip M, Ferrell PB
    Alterations of T-cell-mediated immunity in acute myeloid leukemia.
    Oncogene. 2020 Mar 3. pii: 10.1038/s41388-020-1239.
    PubMed     Abstract available

    February 2020
  20. WANG Y, Liu Y, Bailey C, Zhang H, et al
    Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1alpha with echinomycin.
    Oncogene. 2020 Feb 15. pii: 10.1038/s41388-020-1201.
    PubMed     Abstract available

  21. LOPEZ-GUERRA M, Xargay-Torrent S, Fuentes P, Roldan J, et al
    Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cells.
    Oncogene. 2020;39:1185-1197.
    PubMed     Abstract available

    January 2020
  22. WANG L, Zhao H, Li J, Xu Y, et al
    Identifying functions and prognostic biomarkers of network motifs marked by diverse chromatin states in human cell lines.
    Oncogene. 2020;39:677-689.
    PubMed     Abstract available

    November 2019
  23. BARAK AF, Lewinsky H, Perpinial M, Huber V, et al
    Bone marrow dendritic cells support the survival of chronic lymphocytic leukemia cells in a CD84 dependent manner.
    Oncogene. 2019 Nov 26. pii: 10.1038/s41388-019-1121.
    PubMed     Abstract available

  24. KOUZI F, Zibara K, Bourgeais J, Picou F, et al
    Correction: Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells.
    Oncogene. 2019 Nov 7. pii: 10.1038/s41388-019-1089.
    PubMed     Abstract available

    October 2019
  25. KOUZI F, Zibara K, Bourgeais J, Picou F, et al
    Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells.
    Oncogene. 2019 Oct 24. pii: 10.1038/s41388-019-1069.
    PubMed     Abstract available

  26. PINTO I, Duque M, Goncalves J, Akkapeddi P, et al
    NRARP displays either pro- or anti-tumoral roles in T-cell acute lymphoblastic leukemia depending on Notch and Wnt signaling.
    Oncogene. 2019 Oct 4. pii: 10.1038/s41388-019-1042.
    PubMed     Abstract available

    September 2019
  27. JI D, Zhang P, Ma W, Fei Y, et al
    Oncogenic heterogeneous nuclear ribonucleoprotein D-like modulates the growth and imatinib response of human chronic myeloid leukemia CD34(+) cells via pre-B-cell leukemia homeobox 1.
    Oncogene. 2019 Sep 5. pii: 10.1038/s41388-019-0998.
    PubMed     Abstract available

    August 2019
  28. SECKER KA, Keppeler H, Duerr-Stoerzer S, Schmid H, et al
    Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9.
    Oncogene. 2019 Aug 15. pii: 10.1038/s41388-019-0937.
    PubMed     Abstract available

  29. BUFFIERE A, Uzan B, Aucagne R, Hermetet F, et al
    T-cell acute lymphoblastic leukemia displays autocrine production of Interleukin-7.
    Oncogene. 2019 Aug 15. pii: 10.1038/s41388-019-0921.
    PubMed     Abstract available

    July 2019
  30. HOUNJET J, Habets R, Schaaf MB, Hendrickx TC, et al
    The anti-malarial drug chloroquine sensitizes oncogenic NOTCH1 driven human T-ALL to gamma-secretase inhibition.
    Oncogene. 2019;38:5457-5468.
    PubMed     Abstract available

    June 2019
  31. KRESINSKY A, Schnoder TM, Jacobsen ID, Rauner M, et al
    Lack of CD45 in FLT3-ITD mice results in a myeloproliferative phenotype, cortical porosity, and ectopic bone formation.
    Oncogene. 2019;38:4773-4787.
    PubMed     Abstract available

    April 2019
  32. NICOLAE CM, O'Connor MJ, Schleicher EM, Song C, et al
    PARI (PARPBP) suppresses replication stress-induced myeloid differentiation in leukemia cells.
    Oncogene. 2019 Apr 9. pii: 10.1038/s41388-019-0810.
    PubMed     Abstract available

    March 2019
  33. HIRANO D, Hayakawa F, Yasuda T, Tange N, et al
    Chromosomal translocation-mediated evasion from miRNA induces strong MEF2D fusion protein expression, causing inhibition of PAX5 transcriptional activity.
    Oncogene. 2019;38:2263-2274.
    PubMed     Abstract available

    February 2019
  34. AGUILERA-MONTILLA N, Bailon E, Uceda-Castro R, Ugarte-Berzal E, et al
    MMP-9 affects gene expression in chronic lymphocytic leukemia revealing CD99 as an MMP-9 target and a novel partner in malignant cell migration/arrest.
    Oncogene. 2019 Feb 13. pii: 10.1038/s41388-019-0744.
    PubMed     Abstract available

  35. VAZQUEZ-DOMINGUEZ I, Gonzalez-Sanchez L, Lopez-Nieva P, Fernandez-Navarro P, et al
    Downregulation of specific FBXW7 isoforms with differential effects in T-cell lymphoblastic lymphoma.
    Oncogene. 2019 Feb 11. pii: 10.1038/s41388-019-0746.
    PubMed     Abstract available

    January 2019
  36. SOMERS K, Wen VW, Middlemiss SMC, Osborne B, et al
    A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunction.
    Oncogene. 2019 Jan 22. pii: 10.1038/s41388-018-0666.
    PubMed     Abstract available

  37. KARVONEN H, Perttila R, Niininen W, Hautanen V, et al
    Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting.
    Oncogene. 2019 Jan 10. pii: 10.1038/s41388-018-0670.
    PubMed     Abstract available

  38. LAU BW, Huh K, Madero-Marroquin R, De Marchi F, et al
    Hedgehog/GLI1 activation leads to leukemic transformation of myelodysplastic syndrome in vivo and GLI1 inhibition results in antitumor activity.
    Oncogene. 2019;38:687-698.
    PubMed     Abstract available

  39. CHEN-WICHMANN L, Shvartsman M, Preiss C, Hockings C, et al
    Compatibility of RUNX1/ETO fusion protein modules driving CD34+ human progenitor cell expansion.
    Oncogene. 2019;38:261-272.
    PubMed     Abstract available

    December 2018
  40. SHIRAI YT, Mizutani A, Nishijima S, Horie M, et al
    CNOT3 targets negative cell cycle regulators in non-small cell lung cancer development.
    Oncogene. 2018 Dec 10. pii: 10.1038/s41388-018-0603.
    PubMed     Abstract available

  41. GIANNI M, Terao M, Kurosaki M, Paroni G, et al
    S100A3 a partner protein regulating the stability/activity of RARalpha and PML-RARalpha in cellular models of breast/lung cancer and acute myeloid leukemia.
    Oncogene. 2018 Dec 7. pii: 10.1038/s41388-018-0599.
    PubMed     Abstract available

  42. TRAXEL S, Schadt L, Eyer T, Mordasini V, et al
    Bone marrow T helper cells with a Th1 phenotype induce activation and proliferation of leukemic cells in precursor B acute lymphoblastic leukemia patients.
    Oncogene. 2018 Dec 7. pii: 10.1038/s41388-018-0594.
    PubMed     Abstract available

    November 2018
  43. URTISHAK KA, Wang LS, Culjkovic-Kraljacic B, Davenport JW, et al
    Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia.
    Oncogene. 2018 Nov 26. pii: 10.1038/s41388-018-0567.
    PubMed     Abstract available

    October 2018
  44. MCLEAN K, Tan L, Bolland DE, Coffman LG, et al
    Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth.
    Oncogene. 2018 Oct 10. pii: 10.1038/s41388-018-0523.
    PubMed     Abstract available

  45. CHONG PSY, Zhou J, Chooi JY, Chan ZL, et al
    Non-canonical activation of beta-catenin by PRL-3 phosphatase in acute myeloid leukemia.
    Oncogene. 2018 Oct 10. pii: 10.1038/s41388-018-0526.
    PubMed     Abstract available

    September 2018
  46. CHIANG YJ, Liao WT, Ho KC, Wang SH, et al
    CBAP modulates Akt-dependent TSC2 phosphorylation to promote Rheb-mTORC1 signaling and growth of T-cell acute lymphoblastic leukemia.
    Oncogene. 2018 Sep 28. pii: 10.1038/s41388-018-0507.
    PubMed     Abstract available

  47. CHOW M, Gao L, MacManiman JD, Bicocca VT, et al
    Maintenance and pharmacologic targeting of ROR1 protein levels via UHRF1 in t(1;19) pre-B-ALL.
    Oncogene. 2018;37:5221-5232.
    PubMed     Abstract available

  48. STAMM H, Klingler F, Grossjohann EM, Muschhammer J, et al
    Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option.
    Oncogene. 2018;37:5269-5280.
    PubMed     Abstract available

    August 2018
  49. SWAROOP A, Oyer JA, Will CM, Huang X, et al
    An activating mutation of the NSD2 histone methyltransferase drives oncogenic reprogramming in acute lymphocytic leukemia.
    Oncogene. 2018 Aug 31. pii: 10.1038/s41388-018-0474.
    PubMed     Abstract available

  50. GOROSHCHUK O, Kolosenko I, Vidarsdottir L, Azimi A, et al
    Polo-like kinases and acute leukemia.
    Oncogene. 2018 Aug 13. pii: 10.1038/s41388-018-0443.
    PubMed     Abstract available

    July 2018
  51. FERRANDINO F, Bernardini G, Tsaouli G, Grazioli P, et al
    Intrathymic Notch3 and CXCR4 combinatorial interplay facilitates T-cell leukemia propagation.
    Oncogene. 2018 Jul 23. pii: 10.1038/s41388-018-0401.
    PubMed     Abstract available

  52. NICOLAE CM, O'Connor MJ, Constantin D, Moldovan GL, et al
    NFkappaB regulates p21 expression and controls DNA damage-induced leukemic differentiation.
    Oncogene. 2018;37:3647-3656.
    PubMed     Abstract available

    June 2018
  53. ZHANG Y, Zhou X, Li Y, Xu Y, et al
    Inhibition of maternal embryonic leucine zipper kinase with OTSSP167 displays potent anti-leukemic effects in chronic lymphocytic leukemia.
    Oncogene. 2018 Jun 12. pii: 10.1038/s41388-018-0333.
    PubMed     Abstract available

    May 2018
  54. GERLACH D, Tontsch-Grunt U, Baum A, Popow J, et al
    The novel BET bromodomain inhibitor BI 894999 represses super-enhancer-associated transcription and synergizes with CDK9 inhibition in AML.
    Oncogene. 2018;37:2687-2701.
    PubMed     Abstract available

  55. LIN J, Ma JC, Yang J, Yin JY, et al
    Arresting of miR-186 and releasing of H19 by DDX43 facilitate tumorigenesis and CML progression.
    Oncogene. 2018;37:2432-2443.
    PubMed     Abstract available

    April 2018
  56. PINAZZA M, Ghisi M, Minuzzo S, Agnusdei V, et al
    Histone deacetylase 6 controls Notch3 trafficking and degradation in T-cell acute lymphoblastic leukemia cells.
    Oncogene. 2018 Apr 12. pii: 10.1038/s41388-018-0234.
    PubMed     Abstract available

    March 2018
  57. ZHU Y, Lu L, Qiao C, Shan Y, et al
    Targeting PFKFB3 sensitizes chronic myelogenous leukemia cells to tyrosine kinase inhibitor.
    Oncogene. 2018 Mar 7. pii: 10.1038/s41388-018-0157.
    PubMed     Abstract available

  58. PATRUSSI L, Capitani N, Cattaneo F, Manganaro N, et al
    p66Shc deficiency enhances CXCR4 and CCR7 recycling in CLL B cells by facilitating their dephosphorylation-dependent release from beta-arrestin at early endosomes.
    Oncogene. 2018;37:1534-1550.
    PubMed     Abstract available

    February 2018
  59. ABDUL-AZIZ AM, Shafat MS, Sun Y, Marlein CR, et al
    HIF1alpha drives chemokine factor pro-tumoral signaling pathways in acute myeloid leukemia.
    Oncogene. 2018 Feb 28. pii: 10.1038/s41388-018-0151.
    PubMed     Abstract available

  60. DI COSTANZO A, Del Gaudio N, Conte L, Dell'Aversana C, et al
    The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia.
    Oncogene. 2018 Feb 22. pii: 10.1038/s41388-018-0143.
    PubMed     Abstract available

  61. WANG H, Bei L, Shah CA, Huang W, et al
    The E3 ubiquitin ligase Triad1 influences development of Mll-Ell-induced acute myeloid leukemia.
    Oncogene. 2018 Feb 20. pii: 10.1038/s41388-018-0131.
    PubMed     Abstract available

    January 2018
  62. LARMONIE NSD, Arentsen-Peters TCJM, Obulkasim A, Valerio D, et al
    MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.
    Oncogene. 2018;37:107-115.
    PubMed     Abstract available

    October 2017
  63. HEYDT Q, Larrue C, Saland E, Bertoli S, et al
    Oncogenic FLT3-ITD supports autophagy via ATF4 in acute myeloid leukemia.
    Oncogene. 2017 Oct 23. doi: 10.1038/onc.2017.
    PubMed     Abstract available

  64. ABBACI A, Talbot H, Saada S, Gachard N, et al
    Neurotensin receptor type 2 protects B-cell chronic lymphocytic leukemia cells from apoptosis.
    Oncogene. 2017 Oct 23. doi: 10.1038/onc.2017.
    PubMed     Abstract available

    September 2017
  65. SERIO J, Ropa J, Chen W, Mysliwski M, et al
    The PAF complex regulation of Prmt5 facilitates the progression and maintenance of MLL fusion leukemia.
    Oncogene. 2017 Sep 25. doi: 10.1038/onc.2017.
    PubMed     Abstract available

  66. YOUN H, Lee HK, Sohn HR, Park UH, et al
    RaRF confers RA resistance by sequestering RAR to the nucleolus and regulating MCL1 in leukemia cells.
    Oncogene. 2017 Sep 25. doi: 10.1038/onc.2017.
    PubMed     Abstract available

    August 2017
  67. D'ABUNDO L, Callegari E, Bresin A, Chillemi A, et al
    Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model.
    Oncogene. 2017 Aug 7. doi: 10.1038/onc.2017.
    PubMed     Abstract available

    July 2017
  68. WU TS, Tan CT, Chang CC, Lin BR, et al
    B-cell lymphoma/leukemia 10 promotes oral cancer progression through STAT1/ATF4/S100P signaling pathway.
    Oncogene. 2017 Jul 17. doi: 10.1038/onc.2017.
    PubMed     Abstract available

    June 2017
  69. ZIMMERMANNOVA O, Doktorova E, Stuchly J, Kanderova V, et al
    An activating mutation of GNB1 is associated with resistance to tyrosine kinase inhibitors in ETV6-ABL1-positive leukemia.
    Oncogene. 2017 Jun 26. doi: 10.1038/onc.2017.
    PubMed     Abstract available

  70. KANG SM, Rosales JL, Meier-Stephenson V, Kim S, et al
    Genome-wide loss-of-function genetic screening identifies opioid receptor mu1 as a key regulator of L-asparaginase resistance in pediatric acute lymphoblastic leukemia.
    Oncogene. 2017 Jun 26. doi: 10.1038/onc.2017.
    PubMed     Abstract available

  71. GUO A, Lu P, Lee J, Zhen C, et al
    HSP90 stabilizes B-cell receptor kinases in a multi-client interactome: PU-H71 induces CLL apoptosis in a cytoprotective microenvironment.
    Oncogene. 2017;36:3441-3449.
    PubMed     Abstract available

  72. TSURUTA-KISHINO T, Koya J, Kataoka K, Narukawa K, et al
    Loss of p53 induces leukemic transformation in a murine model of Jak2 V617F-driven polycythemia vera.
    Oncogene. 2017;36:3300-3311.
    PubMed     Abstract available

    April 2017
  73. BURGESS M, Mapp S, Mazzieri R, Cheung C, et al
    Increased FcgammaRIIB dominance contributes to the emergence of resistance to therapeutic antibodies in chronic lymphocytic leukaemia patients.
    Oncogene. 2017;36:2366-2376.
    PubMed     Abstract available

  74. MADAPURA HS, Nagy N, Ujvari D, Kallas T, et al
    Interferon gamma is a STAT1-dependent direct inducer of BCL6 expression in imatinib-treated chronic myeloid leukemia cells.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Abstract available

  75. SOCHALSKA M, Schuler F, Weiss JG, Prchal-Murphy M, et al
    MYC selects against reduced BCL2A1/A1 protein expression during B cell lymphomagenesis.
    Oncogene. 2017;36:2066-2073.
    PubMed     Abstract available

    March 2017
  76. TSAI CT, So CW
    Epigenetic therapies by targeting aberrant histone methylome in AML: molecular mechanisms, current preclinical and clinical development.
    Oncogene. 2017;36:1753-1759.
    PubMed     Abstract available

  77. TAKAHASHI H, Inoue J, Sakaguchi K, Takagi M, et al
    Autophagy is required for cell survival under L-asparaginase-induced metabolic stress in acute lymphoblastic leukemia cells.
    Oncogene. 2017 Mar 27. doi: 10.1038/onc.2017.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.